Founded in 2016, Alpha Tau is an Israeli oncology therapeutics company that focuses on research, development, and potential commercialization of the Alpha DaRT for the treatment of solid tumors. The ...
The Punch on MSN
Eno signs N1.58tn 2026 budget
Governor Umo Eno signs the N1.58tn Akwa Ibom 2026 budget into law, allocating N1.167tn for capital and N416.5bn for recurrent ...
Founded in 2016, Alpha Tau is an Israeli oncology therapeutics company that focuses on research, development, and potential ...
A child who sprains an ankle too often, a teenager living with persistent joint pain, or an adult repeatedly told their ...
AIIMS Delhi has resumed free Therapeutic Drug Monitoring (TDM) tests for epilepsy patients. This initiative reduces financial ...
Billboard Hot 100 re-entries are a relatively common occurrence, as songs often experience sudden gains in activity that help ...
CT scan of chest, abdomen, and pelvis shows high-disease burden, including multiple mediastinal and hilar nodes, deposits in ...
Pegcetacoplan significantly reduces proteinuria in patients with recurrent C3 glomerulopathy, or primary immune-complex ...
It sounds dramatic, but for many women, their favourite leggings may be quietly adding fuel to the fire. They are comfortable ...
The combination of ribociclib and letrozole achieved a 30.6% objective response rate and 84% clinical benefit rate in ...
The biotech will explore the potential of BI-1808 plus Keytruda in clear cell and high-grade serous ovarian cancer subtypes.
Researchers are targeting dormant tumour cells that might explain why some cancers reappear long after successful treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback